Published in BMC Cancer on October 09, 2014
KDM1 class flavin-dependent protein lysine demethylases. Biopolymers (2015) 0.84
KDM4B and KDM4A promote endometrial cancer progression by regulating androgen receptor, c-myc, and p27kip1. Oncotarget (2015) 0.78
Therapeutic opportunities in Ewing sarcoma: EWS-FLI inhibition via LSD1 targeting. Oncotarget (2016) 0.78
Imiquimod Induces Apoptosis in Human Endometrial Cancer Cells In vitro and Prevents Tumor Progression In vivo. Pharm Res (2016) 0.76
Histone demethylases and their roles in cancer epigenetics. J Med Oncol Ther (2016) 0.75
Multimodal Imaging of Orthotopic Mouse Model of Endometrial Carcinoma. PLoS One (2015) 0.75
Reversible lysine-specific demethylase 1 antagonist HCI-2509 inhibits growth and decreases c-MYC in castration- and docetaxel-resistant prostate cancer cells. Prostate Cancer Prostatic Dis (2016) 0.75
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer (2010) 90.16
Cancer statistics, 2012. CA Cancer J Clin (2012) 87.38
Cancer statistics, 2009. CA Cancer J Clin (2009) 83.57
Histone demethylation mediated by the nuclear amine oxidase homolog LSD1. Cell (2004) 21.30
Lysine acetylation targets protein complexes and co-regulates major cellular functions. Science (2009) 20.49
LSD1 demethylates repressive histone marks to promote androgen-receptor-dependent transcription. Nature (2005) 8.53
Cancer epigenetics: from mechanism to therapy. Cell (2012) 7.74
Epigenetics in cancer. Carcinogenesis (2009) 7.49
Two pathogenetic types of endometrial carcinoma. Gynecol Oncol (1983) 6.26
An epigenetic road map for histone lysine methylation. J Cell Sci (2003) 4.43
LSD1 is a subunit of the NuRD complex and targets the metastasis programs in breast cancer. Cell (2009) 3.34
Genome-scale epigenetic reprogramming during epithelial-to-mesenchymal transition. Nat Struct Mol Biol (2011) 3.00
Modes of action of the DNA methyltransferase inhibitors azacytidine and decitabine. Int J Cancer (2008) 2.84
Exome sequencing of serous endometrial tumors identifies recurrent somatic mutations in chromatin-remodeling and ubiquitin ligase complex genes. Nat Genet (2012) 2.71
Lysine-specific demethylase 1 is strongly expressed in poorly differentiated neuroblastoma: implications for therapy. Cancer Res (2009) 2.65
Androgen receptor coactivators lysine-specific histone demethylase 1 and four and a half LIM domain protein 2 predict risk of prostate cancer recurrence. Cancer Res (2006) 2.62
Lysine-specific demethylase 1 (LSD1) is highly expressed in ER-negative breast cancers and a biomarker predicting aggressive biology. Carcinogenesis (2009) 2.54
Overexpression of LSD1 contributes to human carcinogenesis through chromatin regulation in various cancers. Int J Cancer (2011) 2.42
The Ewing's sarcoma oncoprotein EWS/FLI induces a p53-dependent growth arrest in primary human fibroblasts. Cancer Cell (2002) 2.28
The histone demethylase KDM1A sustains the oncogenic potential of MLL-AF9 leukemia stem cells. Cancer Cell (2012) 2.26
Landscape of somatic single-nucleotide and copy-number mutations in uterine serous carcinoma. Proc Natl Acad Sci U S A (2013) 2.02
Loss of trimethylation at lysine 27 of histone H3 is a predictor of poor outcome in breast, ovarian, and pancreatic cancers. Mol Carcinog (2008) 2.01
Requirement of the histone demethylase LSD1 in Snai1-mediated transcriptional repression during epithelial-mesenchymal transition. Oncogene (2010) 1.80
Whole abdominal radiotherapy in the adjuvant treatment of patients with stage III and IV endometrial cancer: a gynecologic oncology group study. Gynecol Oncol (2005) 1.45
Emerging epigenetic targets and therapies in cancer medicine. Cancer Discov (2012) 1.43
The lysine-specific demethylase 1 is required for cell proliferation in both p53-dependent and -independent manners. J Biol Chem (2007) 1.42
Non-endometrioid adenocarcinoma of the uterine corpus: a review of selected histological subtypes. Cancer Control (2009) 1.35
DNA methylation in endometrial cancer. Epigenetics (2010) 1.32
Molecular pathology of endometrial carcinoma: practical aspects from the diagnostic and therapeutic viewpoints. J Clin Pathol (2008) 1.31
Demethylation of RB regulator MYPT1 by histone demethylase LSD1 promotes cell cycle progression in cancer cells. Cancer Res (2010) 1.22
Mechanism and relevance of EWS/FLI-mediated transcriptional repression in Ewing sarcoma. Oncogene (2012) 1.20
Lysine-specific demethylase 1 (LSD1/KDM1A/AOF2/BHC110) is expressed and is an epigenetic drug target in chondrosarcoma, Ewing's sarcoma, osteosarcoma, and rhabdomyosarcoma. Hum Pathol (2012) 1.09
Epigenetic-mediated upregulation of progesterone receptor B gene in endometrial cancer cell lines. Gynecol Oncol (2005) 1.00
High-throughput virtual screening identifies novel N'-(1-phenylethylidene)-benzohydrazides as potent, specific, and reversible LSD1 inhibitors. J Med Chem (2013) 0.98
Prognostic impact of CD133 expression as a tumor-initiating cell marker in endometrial cancer. Hum Pathol (2010) 0.97
Overexpression of lysine specific demethylase 1 predicts worse prognosis in primary hepatocellular carcinoma patients. World J Gastroenterol (2012) 0.97
Lysine-specific demethylase 1 is highly expressed in solitary fibrous tumors, synovial sarcomas, rhabdomyosarcomas, desmoplastic small round cell tumors, and malignant peripheral nerve sheath tumors. Hum Pathol (2011) 0.97
Reversible LSD1 inhibition interferes with global EWS/ETS transcriptional activity and impedes Ewing sarcoma tumor growth. Clin Cancer Res (2014) 0.96
Epigenetic regulation of CD133 and tumorigenicity of CD133 positive and negative endometrial cancer cells. Reprod Biol Endocrinol (2010) 0.95
The emerging genomic landscape of endometrial cancer. Clin Chem (2013) 0.94
Involvement of histone demethylase LSD1 in short-time-scale gene expression changes during cell cycle progression in embryonic stem cells. Mol Cell Biol (2012) 0.94
Selective targeting of histone methylation. Cell Cycle (2011) 0.92
Overexpression of enhancer of zeste homolog 2 (EZH2) and focal adhesion kinase (FAK) in high grade endometrial carcinoma. Gynecol Oncol (2012) 0.91
Inhibition of enhancer of zeste homolog 2 (EZH2) expression is associated with decreased tumor cell proliferation, migration, and invasion in endometrial cancer cell lines. Int J Gynecol Cancer (2013) 0.89
LSD1 regulates pluripotency of embryonic stem/carcinoma cells through histone deacetylase 1-mediated deacetylation of histone H4 at lysine 16. Mol Cell Biol (2013) 0.87
Overview of human primary tumorgraft models: comparisons with traditional oncology preclinical models and the clinical relevance and utility of primary tumorgrafts in basic and translational oncology research. Curr Protoc Pharmacol (2012) 0.85
Histone deacetylase inhibitors induce apoptosis in both Type I and Type II endometrial cancer cells. Gynecol Oncol (2007) 0.81
Immunohistochemical detection of histone deacetylases in endometrial carcinoma: involvement of histone deacetylase 2 in the proliferation of endometrial carcinoma cells. Hum Pathol (2010) 0.80
Ceritinib in ALK-rearranged non-small-cell lung cancer. N Engl J Med (2014) 9.94
A phase I study of intravenous LBH589, a novel cinnamic hydroxamic acid analogue histone deacetylase inhibitor, in patients with refractory hematologic malignancies. Clin Cancer Res (2006) 2.33
Targeting Axl and Mer kinases in cancer. Mol Cancer Ther (2011) 1.88
Diagnosis of common mental disorders by using PRIME-MD Patient Health Questionnaire. Indian J Med Res (2008) 1.81
Dose-escalating and pharmacological study of oxaliplatin in adult cancer patients with impaired renal function: a National Cancer Institute Organ Dysfunction Working Group Study. J Clin Oncol (2003) 1.79
Colon cancer, version 3.2014. J Natl Compr Canc Netw (2014) 1.59
The efficacy of pregabalin for prevention of catheter-related bladder discomfort: a prospective, randomized, placebo-controlled double-blind study. J Anesth (2014) 1.56
Radical resection of rectal cancer primary tumor provides effective local therapy in patients with stage IV disease. Ann Surg Oncol (2002) 1.50
Rectal cancer. J Natl Compr Canc Netw (2012) 1.49
Chlorhexidine to maintain cleanliness of laryngoscope handles: an audit and laboratory study. Eur J Anaesthesiol (2013) 1.46
Metastatic colon cancer, version 3.2013: featured updates to the NCCN Guidelines. J Natl Compr Canc Netw (2013) 1.31
Phase I study of the cyclin-dependent kinase inhibitor flavopiridol in combination with paclitaxel in patients with advanced solid tumors. J Clin Oncol (2002) 1.24
Highly active combination of BRD4 antagonist and histone deacetylase inhibitor against human acute myelogenous leukemia cells. Mol Cancer Ther (2014) 1.18
Localized colon cancer, version 3.2013: featured updates to the NCCN Guidelines. J Natl Compr Canc Netw (2013) 1.17
Dose-escalating and pharmacologic study of oxaliplatin in adult cancer patients with impaired hepatic function: a National Cancer Institute Organ Dysfunction Working Group study. Clin Cancer Res (2007) 1.15
Clinical Cancer Advances 2013: Annual Report on Progress Against Cancer from the American Society of Clinical Oncology. J Clin Oncol (2013) 1.15
Biomarkers for assessment of pharmacologic activity for a vascular endothelial growth factor (VEGF) receptor inhibitor, PTK787/ZK 222584 (PTK/ZK): translation of biological activity in a mouse melanoma metastasis model to phase I studies in patients with advanced colorectal cancer with liver metastases. Cancer Chemother Pharmacol (2005) 1.13
Pharmacology of oxaliplatin in solid tumor patients with hepatic dysfunction: a preliminary report of the National Cancer Institute Organ Dysfunction Working Group. Semin Oncol (2003) 1.12
Acute and chronic animal models for the evaluation of anti-diabetic agents. Cardiovasc Diabetol (2012) 1.02
Phase I study of inhaled Doxorubicin for patients with metastatic tumors to the lungs. Clin Cancer Res (2007) 1.01
Laparoscopic right hemicolectomy with transvaginal colon extraction using a laparoscopic posterior colpotomy: a 2-year series from a single institution. Surg Laparosc Endosc Percutan Tech (2011) 1.00
Oxaliplatin pharmacokinetics and pharmacodynamics in adult cancer patients with impaired renal function. Clin Cancer Res (2007) 0.99
High-throughput virtual screening identifies novel N'-(1-phenylethylidene)-benzohydrazides as potent, specific, and reversible LSD1 inhibitors. J Med Chem (2013) 0.98
Effect of ketoconazole-mediated CYP3A4 inhibition on clinical pharmacokinetics of panobinostat (LBH589), an orally active histone deacetylase inhibitor. Cancer Chemother Pharmacol (2011) 0.98
Antidiabetic and antioxidant potential of Emblica officinalis Gaertn. leaves extract in streptozotocin-induced type-2 diabetes mellitus (T2DM) rats. J Ethnopharmacol (2012) 0.97
Overview for various aspects of the health benefits of Piper longum linn. fruit. J Acupunct Meridian Stud (2011) 0.97
Colon cancer. J Natl Compr Canc Netw (2011) 0.96
Anal Carcinoma, Version 2.2012: featured updates to the NCCN guidelines. J Natl Compr Canc Netw (2012) 0.96
Intrinsic third ventricular craniopharyngiomas: report on six cases and a review of the literature. Surg Neurol (2003) 0.96
Spatially fractionated radiation induces cytotoxicity and changes in gene expression in bystander and radiation adjacent murine carcinoma cells. Radiat Res (2012) 0.96
Preclinical and clinical pharmacodynamic assessment of L-778,123, a dual inhibitor of farnesyl:protein transferase and geranylgeranyl:protein transferase type-I. Mol Cancer Ther (2002) 0.94
Design, Synthesis and Biological Evaluation of a Series of Novel Axl Kinase Inhibitors. ACS Med Chem Lett (2011) 0.93
Assessment of insulin resistance and effect of metformin in nonalcoholic steatohepatitis--a preliminary report. Indian J Gastroenterol (2004) 0.92
Safety, pharmacokinetics, pharmacodynamics, and antitumor activity of dalantercept, an activin receptor-like kinase-1 ligand trap, in patients with advanced cancer. Clin Cancer Res (2013) 0.91
Investigational Aurora A kinase inhibitor alisertib (MLN8237) as an enteric-coated tablet formulation in non-hematologic malignancies: phase 1 dose-escalation study. Invest New Drugs (2014) 0.90
Phase II study of everolimus in patients with metastatic colorectal adenocarcinoma previously treated with bevacizumab-, fluoropyrimidine-, oxaliplatin-, and irinotecan-based regimens. Clin Cancer Res (2013) 0.87
A phase I, open-label, multicenter study to evaluate the pharmacokinetics and safety of oral panobinostat in patients with advanced solid tumors and various degrees of hepatic function. Cancer Chemother Pharmacol (2014) 0.87
Effects of late administration of pentoxifylline and tocotrienols in an image-guided rat model of localized heart irradiation. PLoS One (2013) 0.85
Education effects on the International HIV Dementia Scale. J Neurovirol (2010) 0.85
GC-MS analysis and screening of antidiabetic, antioxidant and hypolipidemic potential of Cinnamomum tamala oil in streptozotocin induced diabetes mellitus in rats. Cardiovasc Diabetol (2012) 0.85
In vitro evaluation of antimicrobial and antioxidant activities of methanolic extract of Jasminum humile leaves. Asian Pac J Trop Med (2011) 0.84
Antiulcer effect of the methanolic extract of Tamarindus indica seeds in different experimental models. J Pharm Bioallied Sci (2011) 0.84
Elizabethkingia meningosepticum : An Emerging Cause of Septicemia in Critically III Patients. J Lab Physicians (2011) 0.84
Colon Cancer, Version 1.2017, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw (2017) 0.83
Aerophagia may not cause gastroesophageal reflux. J Clin Sleep Med (2013) 0.83
Wilson's disease presenting as haemolytic anaemia. J Assoc Physicians India (2009) 0.82
A histone deacetylase inhibitor LBH589 downregulates XIAP in mesothelioma cell lines which is likely responsible for increased apoptosis with TRAIL. J Thorac Oncol (2009) 0.82
Comparative study of the experience of caregiving in bipolar affective disorder and schizophrenia. Int J Soc Psychiatry (2011) 0.82
Antiulcer potential of the ethanolic extract of Aerva persica Merrill root in rats. J Acupunct Meridian Stud (2012) 0.81
Beryllium induces premature senescence in human fibroblasts. J Pharmacol Exp Ther (2007) 0.81
Neuropsychological test performance among healthy persons in northern India: development of normative data. J Neurovirol (2015) 0.81
Phase I studies of CBP501, a G2 checkpoint abrogator, as monotherapy and in combination with cisplatin in patients with advanced solid tumors. Clin Cancer Res (2011) 0.80
Assessment of the drug interaction potential and single- and repeat-dose pharmacokinetics of the BRAF inhibitor dabrafenib. J Clin Pharmacol (2014) 0.80
Slipped capital femoral epiphysis in children aged less than 10 years. J Pediatr Orthop B (2010) 0.80
A phase I clinical pharmacologic study of pralatrexate in combination with probenecid in adults with advanced solid tumors. Cancer Chemother Pharmacol (2005) 0.79
Hypolipidemic and weight reducing activity of the ethanolic extract of Tamarindus indica fruit pulp in cafeteria diet- and sulpiride-induced obese rats. J Pharmacol Pharmacother (2011) 0.79
In vivo anti-hyperglycemic and antioxidant potentials of ethanolic extract from Tecomella undulata. Diabetol Metab Syndr (2012) 0.79
Dimerized glycosaminoglycan chains increase FGF signaling during zebrafish development. ACS Chem Biol (2013) 0.79
Administration of oxaliplatin to patients with renal dysfunction: a preliminary report of the national cancer institute organ dysfunction working group. Semin Oncol (2003) 0.79
Daytime pulse oximetry measurements may not predict nocturnal desaturations in adult sickle cell patients. Ann Hematol (2013) 0.78
Pharmacokinetic drug-drug interaction study of the angiopoietin-1/angiopoietin-2-inhibiting peptibody trebananib (AMG 386) and paclitaxel in patients with advanced solid tumors. Invest New Drugs (2015) 0.78
Of mice and men: opportunities to use genetically engineered mouse models of synovial sarcoma for preclinical cancer therapeutic evaluation. Cancer Control (2011) 0.78
Submental intubation: A useful adjunct in panfacial trauma. Natl J Maxillofac Surg (2010) 0.78
Effects of particle size, food, and capsule shell composition on the oral bioavailability of dabrafenib, a BRAF inhibitor, in patients with BRAF mutation-positive tumors. J Pharm Sci (2013) 0.78
Mycobacterium abscessus bacteremia in an immunocompetent patient following a coronary artery bypass graft. J Cardiovasc Dis Res (2011) 0.77
In vivo assessment of antihyperglycemic and antioxidant activity from oil of seeds of brassica nigra in streptozotocin induced diabetic rats. Adv Pharm Bull (2013) 0.77
Evaluation of analgesic activity of various extracts of Sida tiagii Bhandari. Acta Pol Pharm (2013) 0.77
Screening of antidiabetic and antihyperlipidemic potential of oil from Piper longum and piperine with their possible mechanism. Expert Opin Pharmacother (2013) 0.77
Substituted naphthalen-1-yl-acetic acid hydrazides: synthesis, antimicrobial evaluation and QSAR analysis. Med Chem (2013) 0.77
Erectile dysfunction in diabetes mellitus contributes to poor quality of life. Int Rev Psychiatry (2011) 0.77
Obstructive sleep apnea and coronary artery pathology. Clin Cardiol (2013) 0.76
A randomized, crossover phase 1 study to assess the effects of formulation (capsule vs tablet) and meal consumption on the bioavailability of dovitinib (TKI258). Cancer Chemother Pharmacol (2015) 0.76
Comparative study of proton pump inhibitors for triple therapy in H. pylori eradication. Indian J Gastroenterol (2007) 0.75
A Phase II study of intravenous exatecan administered daily for 5 days, every 3 weeks to patients with biliary tract cancers. Am J Clin Oncol (2005) 0.75
Presence of common mental disorders in patients with diabetes mellitus using a two-stage evaluation method. Indian J Med Res (2015) 0.75
Unusual presentation of a culture-positive right atrial mass. J Cardiovasc Dis Res (2013) 0.75
Anesthetic management of spinal decompression in double vessel coronary artery disease. J Neurosci Rural Pract (2013) 0.75
Phase I trials may not need to be viewed as extraordinarily different from other clinical research. J Clin Oncol (2006) 0.75
Topoisomerase II inhibitors--teaching old dogs new tricks. Cancer Invest (2002) 0.75
Sarcoma immunotherapy. Cancers (Basel) (2011) 0.75
Metastatic pancreatic adenocarcinoma presenting as a large pelvic mass mimicking primary osteogenic sarcoma: a series of two patient cases. J Clin Oncol (2010) 0.75
Wastewater pollution remediation: an experimental investigation with aquatic macrophyte Lemna minor. J Environ Sci Eng (2011) 0.75
Novel intramolecular rearrangement leading to the synthesis of biheterocyclic indole-benzoimidazole derivatives on solid phase. Org Lett (2004) 0.75
Impact of cytochrome P450 3A4 inducer and inhibitor on the pharmacokinetics of trabectedin in patients with advanced malignancies: open-label, multicenter studies. Cancer Chemother Pharmacol (2014) 0.75
An overview for various aspects of multifaceted, health care Tecomella undulata Seem. plant. Acta Pol Pharm (2012) 0.75
Gastroprotection in trauma patients receiving non-steroidal anti-inflammatory drugs. Surgeon (2010) 0.75
Phase 1 trials in oncology in India: the clear case for innovation. J Cancer Res Ther (2009) 0.75
Acute and chronic hypoglycemic activity of Sida tiagii fruits in N5-streptozotocin diabetic rats. Acta Pol Pharm (2012) 0.75
Static jaw collimation settings to minimize radiation dose to normal brain tissue during stereotactic radiosurgery. Med Dosim (2012) 0.75
Patent foramen ovale-obstructive sleep apnea relationships: pro and cons. Cardiovasc Revasc Med (2012) 0.75
Synthesis and assessment of glycosaminoglycan priming activity of cluster-xylosides for potential use as proteoglycan mimetics. ACS Chem Biol (2013) 0.75
Effect of cardiac rehabilitation on inflammatory markers in patients with high risk for obstructive sleep apnea: a pilot study. J Interferon Cytokine Res (2011) 0.75
Hoarseness in a 79 year old woman. BMJ (2013) 0.75
GFI1 functions in transcriptional control and cell fate determination require SNAG domain methylation to recruit LSD1. Biochem J (2017) 0.75
Sleep Overnight Monitoring for Apnea in Patients Hospitalized with Heart Failure (SOMA-HF Study). J Clin Sleep Med (2017) 0.75
Congenital trilobe tongue associated with cleft palate: a rare anomaly. Cleft Palate Craniofac J (2013) 0.75
Determinants of Surgical Site Infections Following Pancreatoduodenectomy. World J Surg (2015) 0.75
Empowering people to change occupational behaviours to address critical global issues. Can J Occup Ther (2015) 0.75
Phase I study to assess the pharmacokinetics and the effect on cardiac repolarization of amrubicin and amrubicinol in patients with advanced solid tumors. Cancer Chemother Pharmacol (2013) 0.75